November 2009

Fri, 09/25/2009 - 13:47 By Sabine Vollmer

Munich Oktoberfest, here I come!

The blog will go on vacation the next two weeks to sample the goods in Germany's wine country southwest of Frankfurt and at the Munich Oktoberfest.

See you back here Oct. 12.


0 Comments
Fri, 09/25/2009 - 01:48 By Sabine Vollmer

RTP Wrapup 9/25

Micell Technologies receives $15 million from St. Jude Medical, GlaxoSmithKline curbs its funding educational programs that bring doctors up-to-date, Duke Genome Center gets a $19.5 million grant and a consortium of area universities and nonprofit organizations are chasing a piece of the $63 billion the Obama Administration wants to spend over the next six years on global health care programs.

Read more...
Tags: rtp, pharma, Duke, UNC, Talecris, GSK 0 Comments
Thu, 09/24/2009 - 21:37 By Sabine Vollmer

Where will tomorrow's energy come from?

Remember cold fusion? Most scientists believe the dream of generating an abundance of cheap energy by fusing two atomic nuclei at room temperature is dead after a 1989 tabletop experiment couldn't be repeated and its results were questioned.

Tom Meyer, a chemistry professor at the University of North Carolina at Chapel Hill, is one of them.

Read more...
Tags: UNC, solar, rtp 0 Comments
Mon, 09/21/2009 - 23:50 By Sabine Vollmer

Triangle is first stop in U.S. global health revamp

When a Washington think tank went looking for ideas to influence how the U.S. might spend $63 billion in the next six years improving the health of people in poor countries, it came to North Carolina's Research Triangle Park.

The RTP area is not only rich in drug researchers and scientists making medical devices with microscopically small nanotechnology, it also has a sizable contingent of global health experts.

Read more...
Tags: UNC, rtp, RTI, FHI, Duke 0 Comments
Mon, 09/21/2009 - 02:44 By Sabine Vollmer

RTP Weekahead 9/21

Events taking place the week of Sept. 21 in the Research Triangle area that are open to the public:

Monday

3 p.m. to 5 p.m.

N.C. Biotechnology Center, 15 T.W. Alexander Drive, Research Triangle Park

Why global health matters to North Carolina

Presented by the Center for Strategic & International Studies Global Health Policy Center and the Triangle Global Health Consortium, the forum will highlight how North Carolina generates knowledge, skills, jobs and partnerships essential to U.S. leadership in global health.

 

Read more...
Tags: rtp, NIEHS, health, biotech 0 Comments
Fri, 09/18/2009 - 04:13 By Sabine Vollmer

RTP Wrapup 9/18

Salix Pharmaceuticals watches its stock soar and Pozen takes action to broaden the scope of the company while GlaxoSmithKline waits for regulatory approval of two vaccines.

Salix soars on rifaximin data

Shares of Salix Pharmaceuticals are up more than 50 percent since the Morrisville company, which specializes in gastrointestinal treatments, announced results from two late-stage studies.

Read more...
Tags: Salix, rtp, Pozen, pharma, H1N1, GSK 0 Comments
Thu, 09/17/2009 - 05:16 By Sabine Vollmer

X-ray scanners get a nanotech makeover

Machines that scan luggage at airports and look inside the body still bear the imprint of Wilhelm Roentgen, the German physics professor who stumbled upon X-rays 114 years ago.

That's because little has changed in the way X-rays are generated: Today's most sophisticated CT scanners produce detailed, three-dimensional images of the heart or the brain with the help of vaccuum tubes that are technologically similar to the one Roentgen used for the iconic image of his wife's hand with rings.

Read more...
Tags: nanotechnology, Siemens, rtp, XinRay 0 Comments
Wed, 09/16/2009 - 14:11 By Sabine Vollmer

Salix soars on rifaximin data

Salix Pharmaceuticals, a Morrisville company that specializes in gastrointestinal treatments, has seen its shares rise nearly 50 percent in the past two days.

Investors rushed to trade the stock after Salix announced results from two late-stage studies Monday that showed rifaximin  works better than placebo in treating non-constipation irritable bowel syndrome. Salix sells rifaximin for traveler's diarrhea under the name Xifaxan.

Read more...
Tags: rtp, Salix, pharma 0 Comments
Mon, 09/14/2009 - 02:35 By Sabine Vollmer

RTP Weekahead 9/14

Events taking place the week of Sept. 14 in the Research Triangle area that are open to the public:

 

Tuesday

11 a.m. to noon

National Institute of Environmental Health Sciences, 111 T.W. Alexander Drive, Research Triangle Park

Rall Bldg. Room D350

Seminar: Inference for marginal linear models for clustered longitudinal data with potentially informative cluster sizes

Speaker: Dr. Somnath Datta, University of Louisville

 

Noon

TARDC luncheon

Read more...
Tags: rtp, biotech, nanotech, NCSU 0 Comments
Fri, 09/11/2009 - 06:39 By Sabine Vollmer

RTP Wrapup 9/11

GlaxoSmithKline gets good news on its Cervarix vaccine and bad news on its blockbuster asthma treatment Advair, the N.C. Biotechnology Center prepares to build a $10.4 million expansion with the help of private donations and Quintiles Transnational gets ready for Clinical Research Education Day at N.C. Central University.

Read more...
Tags: rtp, GSK, biotech, Salix, nanotech 0 Comments